Nesković-Konstantinović Z - Search Results

1

Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.

Nikolić-Vukosavljević D, Markićević M, Grujić-Adanja G, Petrović A, Kanjer K, Nesković-Konstantinović Z. Nikolić-Vukosavljević D, et al. Clin Exp Metastasis. 2005;22(4):363-8. doi: 10.1007/s10585-005-1265-8. Clin Exp Metastasis. 2005. PMID: 16170672

2

Estrogen-regulated cut-off values of pS2 and cathepsin D expression in breast carcinomas.

Markićević M, Petrović A, Kanjer K, Nesković-Konstantinović Z, Nikolić-Vukosavujević D. Markićević M, et al. Adv Exp Med Biol. 2008;617:341-8. doi: 10.1007/978-0-387-69080-3_32. Adv Exp Med Biol. 2008. PMID: 18497057

3

C-myc as a predictive marker for chemotherapy in metastatic breast cancer.

Todorović-Raković N, Nešković-Konstantinović Z, Nikolić-Vukosavljević D. Todorović-Raković N, et al. Clin Exp Med. 2012 Dec;12(4):217-23. doi: 10.1007/s10238-011-0169-y. Epub 2011 Nov 24. Clin Exp Med. 2012. PMID: 22113465

4

Cathepsin D as an indicator of clinical outcome in early breast carcinoma during the first 3 years of follow-up.

Markićević M, Kanjer K, Mandušić V, Buta M, Nešković-Konstantinović Z, Nikolić-Vukosavljević D. Markićević M, et al. Among authors: neskovic konstantinovic z. Biomark Med. 2013 Oct;7(5):747-58. doi: 10.2217/bmm.13.62. Biomark Med. 2013. PMID: 24044567

5

Expression of epidermal growth factor receptor in breast cancer, from early stages to advanced disease.

Nesković-Konstantinović Z, Nikolić-Vukosavljević D, Branković-Magić M, Kanjer K, Gavrilović D, Mitrović L, Borojević N, Vukotić D, Spuzić I. Nesković-Konstantinović Z, et al. J Exp Clin Cancer Res. 1999 Sep;18(3):347-55. J Exp Clin Cancer Res. 1999. PMID: 10606181

6

PS2 protein in breast carcinomas: cut-off value of estrogen-regulated expression.

Nikolić-Vukosavljević D, Grujić-Adanja G, Janković R, Nesković-Konstantinović Z, Branković-Magić M. Nikolić-Vukosavljević D, et al. Neoplasma. 2001;48(1):1-6. Neoplasma. 2001. PMID: 11327531

7

Natural course of node-negative breast cancer: high risk-related subgroups.

Nikolić-Vukosavljević D, Kanjer K, Markicević M, Todorović-Raković N, Vukotić D, Nesković-Konstantinović Z. Nikolić-Vukosavljević D, et al. J Exp Clin Cancer Res. 2003 Dec;22(4):543-9. J Exp Clin Cancer Res. 2003. PMID: 15053295

8

Plasma TGF-beta1-related survival of postmenopausal metastatic breast cancer patients.

Nikolić-Vukosavljević D, Todorović-Raković N, Demajo M, Ivanović V, Nesković B, Markićević M, Nesković-Konstantinović Z. Nikolić-Vukosavljević D, et al. Clin Exp Metastasis. 2004;21(7):581-5. doi: 10.1007/s10585-004-4978-1. Clin Exp Metastasis. 2004. PMID: 15787095

9

Stage-related plasma values of transforming growth factor-beta1 are steroid receptors dependent.

Todorović-Raković N, Nesković-Konstantinović Z, Nikolić-Vukosavljević D. Todorović-Raković N, et al. Clin Exp Med. 2009 Dec;9(4):313-7. doi: 10.1007/s10238-009-0055-z. Epub 2009 May 21. Clin Exp Med. 2009. PMID: 19458909

10

Comparison between immunohistochemistry and chromogenic in situ hybridization in assessing HER-2 status in breast cancer.

Todorović-Raković N, Jovanović D, Nesković-Konstantinović Z, Nikolić-Vukosavljević D. Todorović-Raković N, et al. Pathol Int. 2005 Jun;55(6):318-23. doi: 10.1111/j.1440-1827.2005.01831.x. Pathol Int. 2005. PMID: 15943788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters